TENET HEALTHCARE CORP - Common Stock (THC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
THC on NYSE
Shares outstanding
95,358,080
Price per share
$198.72
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
83,527,653
Total reported value
$16,956,934,963
% of total 13F portfolios
0.02%
Share change
-3,272,696
Value change
-$575,241,549
Number of holders
669
Price from insider filings
$198.72
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TENET HEALTHCARE CORP - Common Stock (THC) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1,004,631,697 8,391,511 BlackRock, Inc. 31 Mar 2025
Invesco Ltd. 4.4% $499,538,404 4,172,556 Invesco Ltd. 31 Mar 2025

As of 30 Sep 2025, 669 institutional investors reported holding 83,527,653 shares of TENET HEALTHCARE CORP - Common Stock (THC). This represents 88% of the company’s total 95,358,080 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of TENET HEALTHCARE CORP - Common Stock (THC) together control 64% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.4% 9,009,590 -4.8% 0.03% $1,829,307,153
BlackRock, Inc. 9% 8,545,762 -4.4% 0.03% $1,735,131,516
FMR LLC 8.3% 7,915,218 -5.6% 0.08% $1,607,105,997
PRICE T ROWE ASSOCIATES INC /MD/ 7.7% 7,370,541 +2% 0.16% $1,496,515,000
Boston Partners 3.3% 3,147,555 +39% 0.66% $638,957,955
STATE STREET CORP 2.9% 2,732,183 -5% 0.02% $554,742,436
GLENVIEW CAPITAL MANAGEMENT, LLC 2.4% 2,323,679 -21% 11% $471,799,784
Invesco Ltd. 2.2% 2,126,551 -24% 0.07% $431,775,008
AQR CAPITAL MANAGEMENT LLC 2% 1,876,423 +62% 0.24% $380,988,867
AMERIPRISE FINANCIAL INC 1.9% 1,836,111 -13% 0.09% $372,805,573
GEODE CAPITAL MANAGEMENT, LLC 1.9% 1,777,985 -18% 0.02% $361,060,783
DIMENSIONAL FUND ADVISORS LP 1.4% 1,332,083 -10% 0.06% $270,447,190
EMINENCE CAPITAL, LP 1.2% 1,109,450 3.3% $225,262,728
BANK OF AMERICA CORP /DE/ 1.1% 1,078,585 +9.6% 0.02% $218,995,899
CITADEL ADVISORS LLC 1.1% 1,055,717 -42% 0.17% $214,352,780
Nuveen, LLC 1.1% 1,031,454 +49% 0.06% $209,426,420
NORTHERN TRUST CORP 0.84% 801,160 -3.6% 0.02% $162,667,525
MORGAN STANLEY 0.83% 794,892 +49% 0.01% $161,395,369
ALLIANCEBERNSTEIN L.P. 0.79% 752,176 -4.8% 0.05% $152,721,815
D. E. Shaw & Co., Inc. 0.78% 744,896 -7.8% 0.12% $151,243,684
MILLENNIUM MANAGEMENT LLC 0.78% 744,352 -26% 0.12% $151,133,230
Bank of New York Mellon Corp 0.76% 720,427 -5.2% 0.03% $146,275,484
RAYMOND JAMES FINANCIAL INC 0.69% 660,588 -1.6% 0.04% $134,125,808
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.67% 635,078 -3.2% 0.02% $128,946,237
VICTORY CAPITAL MANAGEMENT INC 0.65% 616,699 -0.35% 0.08% $125,214,565

Institutional Holders of TENET HEALTHCARE CORP - Common Stock (THC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,267,230 $252,470,384 -$52,769,009 $198.72 68
2025 Q3 83,527,653 $16,956,934,963 -$575,241,549 $203.04 669
2025 Q2 86,705,205 $15,256,042,920 -$242,114,850 $176.00 619
2025 Q1 88,080,538 $11,845,612,578 -$299,492,726 $134.50 553
2024 Q4 90,770,124 $11,459,356,534 +$276,326,951 $126.23 569
2024 Q3 87,251,126 $14,489,253,189 -$596,837,371 $166.20 602
2024 Q2 92,051,436 $12,246,173,959 +$3,595,364 $133.03 531
2024 Q1 92,102,503 $9,680,765,296 -$269,186,776 $105.11 456
2023 Q4 824,001 $62,269,755 -$17,259,692 $75.57 2
2023 Q3 93,995,644 $6,193,258,871 -$66,289,333 $65.89 400
2023 Q2 93,647,137 $7,621,096,221 -$288,876,775 $81.38 405
2023 Q1 99,235,280 $5,894,784,590 -$262,068,762 $59.42 354
2022 Q4 103,039,485 $5,026,743,147 -$178,457,416 $48.79 344
2022 Q3 99,483,375 $5,129,267,513 +$56,809,783 $51.58 338
2022 Q2 99,187,715 $5,207,700,574 -$69,769,655 $52.56 342
2022 Q1 99,165,871 $8,526,718,047 +$252,657,087 $85.96 383
2021 Q4 101,565,630 $8,296,114,558 +$117,782,426 $81.69 358
2021 Q3 100,715,205 $6,692,333,497 +$40,573,013 $66.44 323
2021 Q2 99,239,555 $6,647,962,513 +$208,315,504 $66.99 311
2021 Q1 97,007,612 $5,043,224,072 -$71,180,037 $52.00 302
2020 Q4 98,920,146 $3,950,032,867 -$67,940,180 $39.93 260
2020 Q3 101,348,148 $2,473,220,902 +$1,526,467 $24.51 229
2020 Q2 102,225,865 $1,850,873,999 +$418,200 $18.11 222
2020 Q1 103,222,147 $1,486,519,152 -$56,703,293 $14.40 231
2019 Q4 103,412,197 $3,930,278,051 -$214,905,027 $38.03 252
2019 Q3 109,757,002 $2,426,786,692 +$96,591,819 $22.12 230
2019 Q2 105,706,625 $2,179,764,231 +$60,719,096 $20.66 230
2019 Q1 103,163,517 $2,973,449,017 +$14,136,854 $28.84 246
2018 Q4 101,806,753 $1,744,288,206 -$140,717,728 $17.14 247
2018 Q3 108,873,679 $3,098,070,420 +$64,203,235 $28.46 247
2018 Q2 106,334,145 $3,569,732,267 -$124,012,623 $33.57 240
2018 Q1 111,046,352 $2,692,894,453 -$103,903,895 $24.25 221
2017 Q4 119,325,614 $1,808,980,013 -$113,042,581 $15.16 216
2017 Q3 124,637,401 $2,047,561,626 +$132,539,524 $16.43 221
2017 Q2 117,085,565 $2,264,305,058 +$89,366,386 $19.34 228
2017 Q1 111,920,504 $1,982,020,249 +$463,908,699 $17.71 234
2016 Q4 101,566,502 $1,507,284,820 +$4,844,767 $14.84 242
2016 Q3 98,069,803 $2,220,181,002 -$49,627,538 $22.66 248
2016 Q2 99,403,862 $2,747,445,984 -$46,426,682 $27.64 247
2016 Q1 100,934,480 $2,919,487,257 -$47,387,380 $28.93 257
2015 Q4 102,622,546 $3,109,091,998 -$23,734,562 $30.30 265
2015 Q3 100,393,325 $3,706,156,540 +$41,226,691 $36.92 301
2015 Q2 96,640,269 $5,592,528,480 +$28,177,912 $57.88 324
2015 Q1 98,167,318 $4,857,964,129 +$154,236,555 $49.51 303
2014 Q4 95,005,962 $4,811,432,511 -$87,322,745 $50.67 312
2014 Q3 95,311,225 $5,660,648,364 -$43,039,410 $59.39 302
2014 Q2 97,057,148 $4,555,775,023 +$15,494,537 $46.94 283
2014 Q1 97,946,403 $4,192,168,463 +$227,285,496 $42.81 280